| 产品描述: | Telratolimod (MEDI9197) 是一种有效的 TLR7/8 激动剂,具有抗肿瘤活性。 |
| 靶点: |
TLR7,TLR8;TLR |
| 体外研究: |
Telratolimod (3M-052) is a toll like receptors 7/8 (TLR7/8) agonist, with antitumor activity. |
| 体内研究: |
Telratolimod (50 μg) inhibits the tumor volume, and more potently blocks tumor gowth in combination with CpG ODN in BALB/c mice bearing CT26 colon carcinoma cells. Telratolimod (100 μg) plus 200 μg of CpG ODN slows tumor growth and prolongs survival of mice bearing large tumors. |
| 参考文献: |
1.Zhao BG, et al. Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors. J Immunother Cancer. 2014 May 13;2:12. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.684 ml |
8.419 ml |
16.838 ml |
| 5 mM |
0.337 ml |
1.684 ml |
3.368 ml |
| 10 mM |
0.168 ml |
0.842 ml |
1.684 ml |
| 50 mM |
0.034 ml |
0.168 ml |
0.337 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |